1999
From: American Psychiatric Association
APA Annual Meeting Media Briefings Schedule | WHAT: | Schedule of Media Briefings to be Held at APA MeetingWHERE: | 152nd Annual Meeting of the American Psychiatric Association in Washington, DCWHEN: | May 15 - 20, 1999Briefings will be held in the Washington, DC Convention Center, lobby level, Room 17. Please register as press in the APA Communications Center, lobby level, Room 10.
MONDAY, MAY 17; TUESDAY, MAY 18; WEDNESDAY, MAY 19
9:45 - 10:30 am
"Advances in the Treatment of Insomnia"
Martin Scharf, Ph.D., Center for Sleep Disorders, Cincinnati, OH
Sponsored by Wyeth-Ayerst Laboratories/Edelman Worldwide
9:45 - 10:30 am
"Nefazodone - Chronic Depression Study"
Martin Keller, M.D., Chair Department of Psychiatry and Human Behavior, Brown University School of Medicine
Sponsored by Brown University School of Medicine/Bristol-Myers Squibb Company
9:45 - 10:30 am
"Treating Attention Deficit Hyperactivity Disorder: Avoiding the Stigma and Controversy of In-School Dosing"
Steven Pliszka, M.D., University of Texas; Stephen Grcevich, M.D., Case Western Reserve University; National Association of School Nurses; Mary Robertson, President, Children and Adults with Attention Deficit Disorder.
Sponsored by Shire Richwood, Inc./National Association of School Nurses (NASN), Children and Adults with Attention Deficit Disorder (CHADD)
MONDAY, MAY 17; TUESDAY, MAY 18; WEDNESDAY, MAY 19
1:30 - 2:15 p.m.
"The NARSAD Launches $100 Million Campaign for Mental Illness Research"
Allan Tasman, M.D., APA President-Elect; Herbert Pardes, M.D., President, NARSAD Scientific Council, Vice President Health Sciences, Dean Faculty of Medicine, Chairman of the Department of Psychiatry, The College of Physicians and Surgeons, Columbia University
Sponsored by: National Alliance for the Research of Schizophrenia and Depression (NARSAD)
1:30 - 2:15 p.m.
"Is it All in Your Head? The Relationship Between Depression, Other Medical Illnesses, and the Graying of America"
Dr. Soo Boorson, President, AAGP; Dr. Barry Lebowitz, Chief, Adult and Geriatric Treatment & Preventive Interventions Research Branch, NIMH; Dr. Gary Small, Professor of Psychiatry and Biobehavioral Sciences, UCLA; Dr. Murali Doraiswamy, Associate Professor of Biological Psychiatry, Duke University Medical Center.
Sponsored by: Forest Laboratories & Parke-Davis/American Association for Geriatric Psychiatry (AAGP)
1:30 - 2:15 p.m.
"Exploring the Norepinephrine Pathway in the Treatment of Depression"
Dennis Charney, M.D., Yale University School of Medicine; Alan Schatzberg, M.D., Stanford University Hospital; Maurizio Fava, M.D., Harvard Medical School; Mary Guardino, Founder, Freedom From Fear.
Sponsored by: Pharmacia & Upjohn/Ketchum Public Relations
3:30 - 4:15 p.m.
"Schizophrenia Treatment and the New COPE Program"
Results of a multinational survey of the attitudes and perceptions of healthcare professionals, patients and their caregivers. The launch of COPE, a new program providing practical and useful information for understanding and coping with psychosis-related disorders on a day-to-day basis, also will be announced.
Sponsored by: Zeneca Pharmaceuticals/NAMI/ Burson Marsteller
3:30 - 4:15 p.m.
"Experiencing Schizophrenia"
Dan Frey , schizophrenia patient; Jacob Frey , father of schizophrenia patient; Dr. Stephen Goldfinger, Vice Chair, Psychiatry Department, SUNY Health Sciences University.
Sponsored by: Janssen Pharmaceutica/Ketchum Public Relations
3:30 - 4:15 p.m.
"Remission: Exploring New Treatment Criteria for Depression"
Dr. Michael Thase, Professor of Psychiatry, Research Director, School of Medicine, Pittsburgh, PA, "Exploring Remission and Steps to Achieve It"; Dr. Richard Rudolph, Senior Director, Clinical Research and Development, Wyeth-Ayerst Laboratories, St. David's, Pennsylvania, "Venlafaxine HCl: Achieving Remission and Preventing Relapse Data."
Sponsored by: Wyeth-Ayerst Laboratories/Edelman PR
|
|---|